Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
THCPU
|
Ghisallo Capital Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.0% |
$13,750
$13.75 p/Share
|
Dec 10
2024 |
|
SMLR
|
Douglas Murphy Chutorian
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 53.54% |
$4,572,000
$60.96 p/Share
|
Dec 10
2024 |
|
FYBR
|
Ares Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,500,000 Reduced 0.0% |
$395,255,000
$34.37 p/Share
|
Dec 10
2024 |
|
CSGP
|
John W Hill
Director |
SELL
Open market or private sale
|
Direct | 2,735 Reduced 13.52% |
$209,938
$76.76 p/Share
|
Dec 10
2024 |
|
FYBR
|
Ares Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,500,000 Reduced 0.0% |
$395,255,000
$34.37 p/Share
|
Dec 10
2024 |
|
PHR
|
Evan Roberts
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 3.32% |
$602,250
$24.09 p/Share
|
Dec 10
2024 |
|
WH
|
Michele Allen
CFO & Head of Strategy |
SELL
Open market or private sale
|
Direct | 16,371 Reduced 61.95% |
$1,653,471
$101.0 p/Share
|
Dec 10
2024 |
|
ACVA
|
Michael Waterman
Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 4.25% |
$327,150
$21.81 p/Share
|
Dec 10
2024 |
|
FYBR
|
Ares Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,500,000 Reduced 0.0% |
$395,255,000
$34.37 p/Share
|
Dec 10
2024 |
|
FYBR
|
Ares Management LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 11,500,000 Reduced 0.0% |
$395,255,000
$34.37 p/Share
|
Dec 10
2024 |
|
ACVA
|
George Chamoun
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 210,400 Reduced 19.43% |
$4,553,056
$21.64 p/Share
|
Dec 10
2024 |
|
PCTY
|
Steven I Sarowitz
Director |
SELL
Open market or private sale
|
Direct | 15,293 Reduced 0.18% |
$3,113,807
$203.61 p/Share
|
Dec 10
2024 |
|
OOMA
|
William D Pearce |
SELL
Open market or private sale
|
Direct | 3,700 Reduced 2.21% |
$57,498
$15.54 p/Share
|
Dec 10
2024 |
|
OOMA
|
Shigeyuki Hamamatsu
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 35,313 Reduced 17.6% |
$547,704
$15.51 p/Share
|
Dec 10
2024 |
|
NECB
|
Diane B Cavanaugh
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 29.8% |
$56,900
$28.45 p/Share
|
Dec 10
2024 |
|
HLX
|
Scott Andrew Sparks
EVP & COO |
SELL
Open market or private sale
|
Direct | 170,000 Reduced 60.15% |
$1,677,899
$9.87 p/Share
|
Dec 10
2024 |
|
RNG
|
John H Marlow
SVP, CAdO & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 8,720 Reduced 2.54% |
$366,676
$42.05 p/Share
|
Dec 10
2024 |
|
MDB
|
Dwight A Merriman
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.0% |
$322,800
$322.8 p/Share
|
Dec 10
2024 |
|
MDB
|
Dwight A Merriman
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.09% |
$322,800
$322.8 p/Share
|
Dec 10
2024 |
|
DAWN
|
Samuel C. Blackman
HEAD OF R&D |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 2.82% |
$399,300
$13.31 p/Share
|
Dec 10
2024 |
|
FTDR
|
Kathryn M Collins
SVP & Chief Revenue Officer |
SELL
Open market or private sale
|
Direct | 25,784 Reduced 73.22% |
$1,497,019
$58.06 p/Share
|
Dec 10
2024 |
|
INTA
|
Ralph Baxter
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 34.62% |
$342,299
$68.46 p/Share
|
Dec 10
2024 |
|
HLX
|
Diana Glassman |
SELL
Open market or private sale
|
Direct | 16,000 Reduced 37.97% |
$159,040
$9.94 p/Share
|
Dec 10
2024 |
|
ATOM
|
Robert J Mears
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 2,628 Reduced 2.01% |
$19,867
$7.56 p/Share
|
Dec 10
2024 |
|
BLUE
|
Richard A Colvin
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,824 Reduced 1.68% |
$1,186
$0.42 p/Share
|
Dec 10
2024 |
|
BLUE
|
Andrew Obenshain
President and CEO |
SELL
Open market or private sale
|
Direct | 971 Reduced 0.26% |
$407
$0.42 p/Share
|
Dec 10
2024 |
|
OMCL
|
Mark W Parrish |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 17.04% |
$567,600
$47.3 p/Share
|
Dec 10
2024 |
|
HWBK
|
Jonathan Holtaway
Director |
SELL
Open market or private sale
|
Indirect | 7,424 Reduced 0.0% |
$237,939
$32.05 p/Share
|
Dec 10
2024 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,320 Reduced 0.0% |
$206,121
$12.63 p/Share
|
Dec 10
2024 |
|
NMAI
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,719 Reduced 0.0% |
$214,671
$12.84 p/Share
|
Dec 10
2024 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 7,284 Added 0.0% |
$89,301
$12.26 p/Share
|
Dec 10
2024 |
|
ENX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,410 Added 0.0% |
$23,883
$9.91 p/Share
|
Dec 10
2024 |
|
BKE
|
Kari G Smith
EVP Stores |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$1,045,800
$52.29 p/Share
|
Dec 10
2024 |
|
CULP
|
Robert George Iv Culp
President and CEO |
BUY
Open market or private purchase
|
Direct | 8,508 Added 9.83% |
$46,113
$5.42 p/Share
|
Dec 10
2024 |
|
AUID
|
Thomas Robert Szoke
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 5.71% |
$6,300
$6.3 p/Share
|
Dec 10
2024 |
|
IOT
|
Andreessen Horowitz Lsv Fund Iii, L.P. |
SELL
Open market or private sale
|
Indirect | 112,380 Reduced 0.0% |
$5,265,003
$46.85 p/Share
|
Dec 10
2024 |
|
IOT
|
Andreessen Horowitz Lsv Fund I, L.P. |
SELL
Open market or private sale
|
Indirect | 112,380 Reduced 0.0% |
$5,265,003
$46.85 p/Share
|
Dec 10
2024 |
|
IOT
|
Ah Parallel Fund Iv, L.P. |
SELL
Open market or private sale
|
Indirect | 112,380 Reduced 0.0% |
$5,265,003
$46.85 p/Share
|
Dec 10
2024 |
|
IOT
|
Marc L Andreessen |
SELL
Open market or private sale
|
Indirect | 112,380 Reduced 0.0% |
$5,265,003
$46.85 p/Share
|
Dec 10
2024 |
|
NTRA
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct | 1,767 Reduced 22.17% |
$300,814
$170.24 p/Share
|
Dec 10
2024 |
|
PAYS
|
Mark Newcomer
CEO |
SELL
Open market or private sale
|
Direct | 59,000 Reduced 0.64% |
$188,210
$3.19 p/Share
|
Dec 10
2024 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 35,921 Reduced 0.0% |
$22,249,467
$619.4 p/Share
|
Dec 10
2024 |
|
PX
|
210 Capital, LLC |
SELL
Open market or private sale
|
Indirect | 145,000 Reduced 0.0% |
$1,940,100
$13.38 p/Share
|
Dec 10
2024 |
|
DOCU
|
Daniel D. Springer
Director |
SELL
Open market or private sale
|
Direct | 581,588 Reduced 39.08% |
$57,152,652
$98.27 p/Share
|
Dec 10
2024 |
|
PAYO
|
Tsafi Goldman
Chief Legal & Regulatory Ofcr. |
SELL
Open market or private sale
|
Direct | 263,873 Reduced 26.24% |
$2,665,117
$10.1 p/Share
|
Dec 10
2024 |
|
GDYN
|
Anil Doradla
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 18,039 Reduced 4.83% |
$360,780
$20.0 p/Share
|
Dec 10
2024 |
|
OLMA
|
Naseem Zojwalla
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 13,283 Reduced 9.27% |
$124,461
$9.37 p/Share
|
Dec 10
2024 |
|
OLMA
|
David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct | 12,452 Reduced 1.99% |
$116,799
$9.38 p/Share
|
Dec 10
2024 |
|
OLMA
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct | 8,256 Reduced 1.06% |
$77,358
$9.37 p/Share
|
Dec 10
2024 |
|
OLMA
|
Sean Bohen
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 52,328 Reduced 14.9% |
$490,313
$9.37 p/Share
|
Dec 10
2024 |